“Tim has had a remarkable 30-year career within the pharmaceutical industry,” noted Patrick E. Hobbs, Dean of Seton Hall Law School. “He has held leadership positions in five major pharmaceutical companies and is a leading voice today in promoting the advancement of best practices in compliance and business ethics. As a member of the Law School’s Board of Visitors, he also brings his vision to our Health Law and Policy Program.”

Rothwell began his career at Sandoz Pharmaceuticals in 1972 in the legal department, subsequently moving into sales and marketing and then into the position of Chief Operating Officer. In 1989, he joined the Squibb Corporation as Senior Vice President of Marketing and Sales for the U.S. In 1991, he moved to Burroughs Wellcome where he was appointed Vice President, Global Sales and Marketing. He then returned to Sandoz and was named Chief Executive Officer.

Before assuming his current position, he had served as President and CEO of Sanofi-Synthelabo Inc, as President of Pharmacia’s Global Prescription Business and Executive Vice President of Pharmacia Corporation, and as worldwide President of Rhone-Poulenc Rorer Pharmaceuticals and President of the company’s Global Pharmaceutical Operation.

Currently, he serves on the PhRMA Board of Directors, the Healthcare Businesswomen’s Association Advisory Board, and the Board of Trustees for both the Somerset Medical Center Foundation and Health Institute of New Jersey, in addition to serving on Seton Hall Law School’s Board of Visitors.

The only private law school in New Jersey, Seton Hall University School of Law was founded in 1951, and is located in the city of Newark. Seton Hall Law School offers both day and evening programs leading to the Juris Doctor (J.D.), Master of Laws (LL.M.) and Master of Science in Jurisprudence (M.S.J.) degrees. For more information on Seton Hall Law School, visit law.shu.edu.